TY - JOUR
T1 - Unmet medical needs and other challenges in the treatment of patients with schizophrenia
AU - Goldstone, Lisa W.
N1 - Publisher Copyright:
© 2020 Ascend Media. All rights reserved.
PY - 2020/4
Y1 - 2020/4
N2 - Schizophrenia is a chronic mental health disorder hallmarked by a variety of symptoms impacting mental state, emotions, and behaviors, including delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, negative symptoms, and cognitive impairment. Schizophrenia leaves patients with the inability to function appropriately in their daily lives, including at work, in relationships, and even with self-care. The exact cause of this disorder has yet to be elucidated; however, multiple factors, including genetic susceptibility and environmental influences, have been implicated in its development. Patients with schizophrenia frequently demonstrate medication nonadherence and have multiple concurrent comorbidities that lead to increased morbidity and mortality. Schizophrenia is estimated to affect more than 21 million individuals globally, and while many therapies have become available for management, the disorder still presents unique challenges to providers, caregivers, and the healthcare system. Unmet medical needs remain for this complex disease state, and research is ongoing to address these needs and improve the overall health and outcomes of patients living with schizophrenia.
AB - Schizophrenia is a chronic mental health disorder hallmarked by a variety of symptoms impacting mental state, emotions, and behaviors, including delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, negative symptoms, and cognitive impairment. Schizophrenia leaves patients with the inability to function appropriately in their daily lives, including at work, in relationships, and even with self-care. The exact cause of this disorder has yet to be elucidated; however, multiple factors, including genetic susceptibility and environmental influences, have been implicated in its development. Patients with schizophrenia frequently demonstrate medication nonadherence and have multiple concurrent comorbidities that lead to increased morbidity and mortality. Schizophrenia is estimated to affect more than 21 million individuals globally, and while many therapies have become available for management, the disorder still presents unique challenges to providers, caregivers, and the healthcare system. Unmet medical needs remain for this complex disease state, and research is ongoing to address these needs and improve the overall health and outcomes of patients living with schizophrenia.
UR - http://www.scopus.com/inward/record.url?scp=85083383466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083383466&partnerID=8YFLogxK
U2 - 10.37765/AJMC.2020.43011
DO - 10.37765/AJMC.2020.43011
M3 - Article
C2 - 32282174
AN - SCOPUS:85083383466
SN - 1088-0224
VL - 26
SP - S48-S54
JO - American Journal of Managed Care
JF - American Journal of Managed Care
IS - 3
ER -